Virology
Feline immunodeficiency virus restriction by Ref1, Lv1, and TRIM5 alpha proteins is examined
Published in AIDS Weekly, March 20th, 2006
"The Ref1 and Lv1 post-entry restrictions in human and monkey cells have been analyzed for lentiviruses in the primate and ungulate groups, but no data exist for the third (feline) group. We compared feline immunodeficiency virus (FIV) to other restricted (human immunodeficiency virus type 1 [HIV-1], equine infectious anemia virus [EIAV]) and unrestricted (NB-tropic murine leukemia virus [NB-MLV]) retroviruses across wide ranges of viral inputs in cells from multiple primate and nonprimate species,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-03-20)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Genotypic and phenotypic clinical cut-off levels determined for ritonavir-boosted saquinavir - HIV/AIDS Drug Resistance
Infant-only prophylaxis eliminates nevirapine resistance development in mothers and infants - HIV/AIDS Pharmacokinetics
Interpatient variability in plasma efavirenz levels determined by gender and race - HIV/AIDS Transmission
Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B - Pediatrics HIV/AIDS Risk Factors
Infants perinatally infected with HIV at risk from BCG vaccination - Business Update
Blood safety scientific advisory board established by Cerus - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
